Health & pharmaceuticals news

Meme stock Cassava Sciences Inc. (NASDAQ:SAVA) shares surged more than 27% on Wednesday after revealing plans to present data on its Alzheimer’s drug, Simufilam, on 29th July. Cassava will read out its interim analysis on a 9-month treatment with Simulflam at the 2021 Alzheimer’s Association International…

Moderna Inc. (NASDAQ:MRNA)became the latest addition to the S&P 500 Index. The company will officially join the list on 27th July to start enjoying the benefits of belonging to an elite class of companies. The MRNA stock price surged more than 9%…

The medical community has not been entirely convinced of the U.S. FDA’s decision to approve Biogen Inc’s (NASDAQ: BIIB) Aduhelm drug to treat Alzheimer’s last month. Some health insurers also declined coverage for Aduhelm The latest blow to the biotech firm came late on Thursday when Providence, Mount Sinai…

UnitedHealth Group Inc (NYSE: UNH) said on Thursday its profit and revenue in the fiscal second quarter topped Wall Street estimates by a significant margin. The health care provider acknowledged that the pandemic was likely to keep weighing on results. Still, it raised its guidance for the full year.

Meme stock Clover Health Investment Corp (NASDAQ:CLOV) on Wednesday extended this week’s losses to 16% following the expiry of the 180-day share lock-up period.  Clover Health went public on 8th January via the SPAC Social Capital Hedosophia Holdings Corp. III. The stock traded in choppy pattern…

Philip Morris International Inc (NYSE: PM) said on Friday it will buy Vectura Group plc (LON: VEC) for £1.05 billion as part of its push to expand its products portfolio beyond nicotine. The Marlboro cigarette maker’s deal translates to 150 pence per share in cash for Vectura stockholders…

Apollo Medical Holdings Inc (NASDAQ: AMEH) has gained more than 20% in value this week on no notable news event. In fact, the last catalyst that would have driven Apollo Medical stock higher was back on June 11 when the company said it would be included in the S&P…

French pharmaceutical giant Sanofi SA (LON:0O59) said Monday its Covid-19 vaccine developed in partnership with UK Pharma GlaxoSmithKline Plc (NYSE:GSK) could be ready for roll-out by December. Sanofi is one of the few global vaccine developers yet to roll out a Covid-19 vaccine, but things could…

Biopharmaceutical player, Alector Inc. (NASDAQ: ALEC), has skyrocketed in value this week by 90%, leading an increased number of investors to investigate the stock in more detail.  In light of this increased demand, we thought it would be helpful to release an article explaining everything you need to know…

Walgreens Boots Alliance Inc. (NASDAQ: WBA) published its earnings report for the fiscal third quarter on Thursday that topped analysts’ estimates for earnings and revenue. Shares of the company still slid about 7% on Thursday morning. Glen Santangelo’s comments on Walgreens’ earnings report Commenting on the quarterly results, Guggenheim…

While the coronavirus pandemic has battered small businesses around the world and sent industries like hospitality and aviation into crisis, times have been good for many of the world’s megafirms.  The 100 biggest technology companies grew by a cumulative 71% in the year from March 2020, and those at the…

Intellia Therapeutics Inc (NASDAQ: NTLA) said on Saturday its clinical trial that used Crispr technology to treat a genetic disorder inside the human body showed positive results. The biotech company had collaborated with Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on the study that used the Nobel Prize-winning technology. Intellia…

Rite Aid Corp (NYSE:RAD) shares plunged 13% Thursday morning after the company’s most recent quarterly report. RAD reported earnings the beat expectations on Thursday morning, but revenues came short of estimates. Shares fell after the company issued tepid guidance on fiscal 2022 revenue and earrings. RAD…

Rite Aid Corp. (NYSE: RAD) said on Thursday its revenue in the fiscal first quarter came in weaker than expected, attributed to the pharmacy services business. Its Q1 profit, however, topped Wall Street estimates. The stock slipped about 12% on Thursday morning. Rite Aid’s Q1 financial results Rite Aid…

GlaxoSmithKline plc (LON: GSK) said on Wednesday its consumer healthcare business will be spun off into a separately listed company. The demerger that was originally announced in December 2018 will eventually result in an $11 billion payment for GSK. Following the separation scheduled for mid-2022, GlaxoSmithKline will focus on…

Peloton Interactive Inc. (NASDAQ: PTON) launched a corporate wellness program on Tuesday as the company seeks to reach more customers and expand its user base.  With the launch, businesses signing up will offer their employees subsidized Peloton digital fitness membership to access its treadmills and high-end cycles. Peloton…

The Honest Company (NASDAQ: HNST) has reported mixed first quarter results on Wednesday that resulted in shares trading lower 8% Thursday morning. Q1 recap: sales beat overshadowed by losses Honest Co reported a sales beat in the first quarter of $81.03 million versus expectations…

CureVac NV (NASDAQ: CVAC) slipped about 45% in the stock market on Thursday morning as the company said the late-stage trial showed its candidate COVID-19 vaccine to be only 47% effective, raising questions on the German biotech’s agreement with the European Union to deliver hundreds of millions of doses…

Elanco Animal Health Inc (NYSE: ELAN) said on Wednesday it will acquire Kindred Biosciences Inc (NASDAQ: KIN) for roughly $440 million (£312 million) to expand its footprint in the pet health industry. The acquisition will bring three potential dermatology blockbusters, which are currently in the development phase, under…

Sage Therapeutics Inc (NASDAQ: SAGE) said on Tuesday its candidate drug for depression that it developed in collaboration with Biogen Inc was found effective in alleviating the symptoms, as per the results of the late-stage trial. Despite meeting the goal of the study, Sage’s stock tanked about 18% this…

AstraZeneca plc (LON:AZN) released its ‘Storm Chaser’ study results on Tuesday that at first glance appear disappointing but beyond the headline takeaway, there were some positives. The trial assessed both the efficacy and safety of the LAAB (long-acting antibody) combination, AZD7442, designed to battle the SARS-CoV-2 virus.

Novavax Inc (NASDAQ: NVAX) said on Monday its candidate COVID-19 vaccine showed 93% efficacy in its U.S. late-stage trial. The results of the clinical trial also confirmed the vaccine to be effective against a range of predominant Coronavirus variants. Novavax’s head of R&D, Dr Gregory Glenn, said: “Practically…